We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.98B
2
META icon
Meta Platforms (Facebook)
META
+$997M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$860M
4
WDAY icon
Workday
WDAY
+$691M
5
AMZN icon
Amazon
AMZN
+$616M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$498M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$420M
3
FDX icon
FedEx
FDX
+$350M
4
VALE icon
Vale
VALE
+$340M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$322M

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOGP
12451
Sound Group
SOGP
$53M
$27K ﹤0.01%
1,778
-1,993
-53% -$29.6K
TOPS icon
12452
TOP Ships
TOPS
$4.21M
$27K ﹤0.01%
107
-58
-35% -$13.5K
SGTX
12453
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$27K ﹤0.01%
1,389
-1,928
-58% -$43K
AGTC
12454
DELISTED
Applied Genetic Technologies Corporation
AGTC
$27K ﹤0.01%
25,523
-53,323
-68% -$96.9K
CFMS
12455
DELISTED
Conformis, Inc. Common Stock
CFMS
$27K ﹤0.01%
1,698
+1,263
+290% +$20.8K
ATHE
12456
Alterity Therapeutics
ATHE
$80.8M
$26K ﹤0.01%
3,188
-2,971
-48% -$24.7K
KRRO icon
12457
PUT
Korro Bio
KRRO
$193M
$26K ﹤0.01%
242
+4
+2% +$764
LGHL
12458
PUT
Lion Group Holding
LGHL
$489K
– –
0
– –
OGEN icon
12459
Oragenics
OGEN
$2.39M
$26K ﹤0.01%
42
+3
+8% +$2.2K
ORN icon
12460
PUT
Orion Group Holdings
ORN
$377M
$26K ﹤0.01%
+10,400
New +$31.8K
VGZ icon
12461
Vista Gold
VGZ
$326M
$26K ﹤0.01%
+24,542
New +$20.2K
PFIE
12462
DELISTED
Profire Energy, Inc
PFIE
$26K ﹤0.01%
20,030
-18,668
-48% -$22.2K
NTBL
12463
PUT
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$26K ﹤0.01%
443
-128
-22% -$6.52K
MOTS
12464
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$26K ﹤0.01%
+245
New +$28.6K
ONCT
12465
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$26K ﹤0.01%
930
+105
+13% +$3.82K
PHUNW
12466
DELISTED
Phunware, Inc. Warrants
PHUNW
$26K ﹤0.01%
19,441
+4,592
+31% +$8.22K
MDNA
12467
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$26K ﹤0.01%
+20,861
New +$32.4K
APTX
12468
CALL
DELISTED
Aptinyx Inc. Common Stock
APTX
$26K ﹤0.01%
+11,500
New +$34.5K
KRBP
12469
CALL
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$26K ﹤0.01%
1,037
-1,066
-51% -$31.5K
ABTS icon
12470
PUT
Abits Group
ABTS
$4.31M
$25K ﹤0.01%
1,027
-5,566
-84% -$164K
FLNT
12471
Fluent
FLNT
$110M
$25K ﹤0.01%
2,027
-10,209
-83% -$104K
LITB
12472
LightInTheBox
LITB
$64.1M
$25K ﹤0.01%
3,937
+1,177
+43% +$7.87K
CD
12473
CALL
Chaince Digital Holdings
CD
$378M
$25K ﹤0.01%
9,360
-810
-8% -$2.43K
PRSO icon
12474
Peraso
PRSO
$9.6M
$25K ﹤0.01%
285
-307
-52% -$32.8K
RKDA icon
12475
CALL
Arcadia Biosciences
RKDA
$1.28M
$25K ﹤0.01%
445
-123
-22% -$5.87K
497 498
499
500 501

Similar funds

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.